Dr. Hwee Ching Ang, is Deputy Chief Executive Officer (DCE) at EDDC. She was previously acting COO of NTUitive, the innovation and enterprise company of the Nanyang Technological University, Singapore (ranked World’s Top Young University, 2013-2018 by QS).

Prior to this, she was Head of Bayer’s Innovation Centre Singapore, where she was part of the Global External Innovation and Alliances team and responsible for partnering activities in Asia Pacific (excluding China, Japan). Before joining Bayer in 2011, Dr. Ang was Deputy Director at the Biomedical Sciences Industry Partnership Office, a multi-agency office set up to work with biomedical sciences companies and drive partnering activities with Singapore institutions.

Over the years, Dr. Ang has set up and managed a number of public-private research partnerships from both academic and industry sides. She was previously responsible for Business Development, Project Management and Alliance Management at the Lilly Singapore Centre for Drug Discovery and at the A*STAR Experimental Therapeutics Centre where she was part of the start-up team led by Prof. Sir David Lane. She has also worked on strategic initiatives to build the Singapore biomedical industry and was part of a team evaluating grant and equity support for biotech companies while at the Singapore Economic Development Board.

Hwee Ching completed her undergraduate studies in Chemical Engineering and Finance, and a master’s degree in Biotechnology at the University of Pennsylvania (US) and her Ph.D. studies with Prof. Sir Alan Fersht at the MRC Centre for Protein Engineering at Cambridge University (UK).